The Trip Report by Beckley Waves
The Trip Report
#10: Hadas Alterman - What We Talk About When We Talk About Psychedelic Infrastructure

#10: Hadas Alterman - What We Talk About When We Talk About Psychedelic Infrastructure

Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.

Today, The Trip Report is speaking with Hadas Alterman, and let me warn you, you are in for a doozy.

Hadas is the Director of Communications and Policy at the American Psychedelic Practitioners Association (APPA), and in this conversation, we leave no stone unturned.

We discuss APPA, the organization, the mission, and the specific work they’re doing to support psychedelic therapists, guides, and facilitators.

But we also dive into the concept of power and influence and how these forces are shaping the emerging psychedelic ecosystem.

We get into the weeds on the most important legal and policy topics in the psychedelic space right now, like the influence of Big Pharma on the DEA and how that is affecting the field now and could in the future.

We talk about “The Establishment” and the institutions that have outsized influence on the path of the psychedelic emergence, including the FDA’s meddling with the practice of medicine, most famously during COVID and now with public comments on the use of off-label ketamine.

We also discuss:

  • Bridging the wisdom of the underground and traditional lineages with the modern medical system;

  • The process of bringing together stakeholders from different parts of the psychedelic ecosystem for constructive dialogue and consensus-building;

  • The varieties of psychedelic access routes and the tradeoffs inherent in them; and

  • The current geopolitical situation unfolding in the Middle East.

And now, without further ado, I bring you my conversation with Hadas Alterman.

Listen to the episode on Substack, Spotify, Google or Apple.


The Trip Report by Beckley Waves
The Trip Report
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance.